Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

ANIP
ANI Pharmaceuticals, Inc.
stock NASDAQ

Market Open
Jun 30, 2026 11:10:41 AM EDT
83.65USD-0.553%(-0.47)29,478
83.42Bid   83.88Ask   0.46Spread
Pre-market
Jun 30, 2026 8:32:30 AM EDT
85.00USD+1.052%(+0.89)200
After-hours
Jun 29, 2026 4:00:30 PM EDT
84.12USD-0.018%(-0.02)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
07:08AM EST  ANI Pharmaceuticals, Inc. (ANIP) announced Monday the U.S. commercial availability of Purified Cortrophin Gel (Repository Corticotropin Injection USP) 80 U/mL. The commercial launch of Cortrophin Gel, an adrenocorticotropic hormone (ACTH), also known as purified corticotropin, is being led by ANI's recently established rare disease business unit.   RTTNews
06:59AM EST  ANI Announces Commercial Availability Of Purified Cortrophin Gel For Multiple Chronic Autoimmune Disorders   RTTNews
06:53AM EST  ANI Pharmaceuticals Announces Commercial Availability Of Purified Cortrophin Gel For Multiple Chronic Autoimmune Disorders   Benzinga
06:50AM EST  ANI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin(tm) Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune Disorders   Business Wire
Jan 12, 2022
12:46PM EST  ANI Pharma Shares Quiet Amid Headline Fair Trade Commission Has Okayed Final Order Requiring ANI Pharma, Novitium Pharma To Divest Rights, Assets To Generic Sulfam   Benzinga
Jan 3, 2022
04:30PM EST  ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference   Business Wire
Dec 21, 2021
08:19AM EST  ANI Pharmaceuticals Inc. (ANIP) said on Tuesday that it has received FDA approval for a generic version of Pfizer's Mycobutin.   RTTNews
08:12AM EST  The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail   Benzinga
06:56AM EST  ANI Pharma Receives FDA Approval For ANDA For Rifabutin Capsules USP, 150 Mg   RTTNews
06:50AM EST  ANI Pharmaceuticals Announces FDA Approval And Imminent Launch Of Rifabutin Capsules USP   Benzinga
Dec 20, 2021
07:41AM EST  Eton Pharma And ANI Pharma Announce Commercial Availability Of Carglumic Acid Tablets   RTTNews
07:31AM EST  Eton Pharmaceuticals And ANI Pharmaceuticals Announce Commercial Availability Of Carglumic Acid Tablets, The First And Only FDA-Approved Generic Version Of Carbaglu   Benzinga
07:30AM EST  -- Product is now available exclusively through Anovo specialty pharmacy -- Product is stable at room temperature while Carbaglu requires refrigeration -- Eton Cares patient support program will offer $0 co-pays to commercial insurance patients   GlobeNewswire Inc
Dec 17, 2021
04:22PM EST  ANI Pharma S-3 Shows Registration For ~3.07M Share Common Stock Shelf Offering   Benzinga
Nov 22, 2021
06:57AM EST  ANI Pharmaceuticals Closes Acquisition Of Novitium Pharma   RTTNews
06:50AM EST  ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses   Business Wire
06:40AM EST  ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021   Business Wire
Nov 11, 2021
07:25AM EST  ANI Pharmaceuticals, Inc. (ANIP) Thursday said the U.S. Federal Trade Commission has accepted the proposed consent order to acquire Novitium Pharma. As per the agreement, FTC's acceptance satisfies all required antitrust clearances. ANI, a diversified biopharmaceutical company, further noted that the acquisition will be completed on or about November 18, 2021.   RTTNews
06:57AM EST  ANI Pharma Gets Clearance From U.S. Federal Trade Commission For Acquisition Of Novitium Pharma   RTTNews
06:54AM EST  ANI Pharmaceuticals Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of Novitium Pharma   Benzinga
Nov 8, 2021
04:07PM EST  ANI Pharmaceuticals, Inc. Announces Closing of $75 Million Public Offering of Common Stock   Business Wire
Nov 4, 2021
08:19AM EDT  The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO   Benzinga
Nov 3, 2021
10:54PM EDT  ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million Public Offering of Common Stock   Business Wire
05:34PM EDT  ANI Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock; No Terms Diclosed   Benzinga
04:03PM EDT  ANI Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock   Business Wire
Nov 2, 2021
11:11AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021   Benzinga
10:50AM EDT  Raymond James Maintains Outperform on ANI Pharmaceuticals, Raises Price Target to $65   Benzinga
10:47AM EDT  Truist Securities Initiates Coverage On ANI Pharmaceuticals with Buy Rating, Announces Price Target of $70   Benzinga
Nov 1, 2021
03:23PM EDT  Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide   Benzinga
12:14PM EDT  Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump   Benzinga
12:05PM EDT  ANI Pharmaceuticals's Return On Capital Employed Overview   Benzinga
10:35AM EDT  Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views   Benzinga
07:03AM EDT  Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) reported Monday a third-quarter net loss of $4.45 million or $0.37 per share, compared to net income of $0.43 million or $0.04 per share in the prior-year quarter.   RTTNews
06:48AM EDT  ANI Pharma Reports Q3 Adj. EPS Of $1.01   RTTNews
06:46AM EDT  ANI Pharmaceuticals Q3 EPS $1.01 Beats $0.70 Estimate, Sales $52.10M Beat $49.70M Estimate   Benzinga
06:45AM EDT  ANI Pharmaceuticals Reports Third Quarter 2021 Results   Business Wire
06:44AM EDT  ANI Pharmaceuticals, Inc. (ANIP, BPAX) announced FDA has approved its supplemental New Drug Application (sNDA) for Purified Cortrophin Gel for the treatment of certain chronic autoimmune disorders including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome. The company anticipates a full-scale commercial launch by early in the first quarter of 2022.   RTTNews
06:35AM EDT  ANI Announces FDA Approval Of Purified Cortrophin Gel For Treatment Of Certain Chronic Autoimmune Disorders   RTTNews
06:31AM EDT  ANI Pharmaceuticals Announces FDA Approval Of Purified Cortrophin Gel For Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis And Nephrotic Syndrome   Benzinga
04:01AM EDT  Earnings Scheduled For November 1, 2021   Benzinga
Oct 29, 2021
04:30PM EDT  ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021   Business Wire
08:00AM EDT  The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs   Benzinga
Oct 25, 2021
09:07AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Monday, Oct. 25, 2021: AAPL, MSFT, HOOD, IMAX, ANIP   Benzinga
Oct 24, 2021
11:45AM EDT  The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More   Benzinga
Oct 1, 2021
02:29PM EDT  Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates   Benzinga
Sep 20, 2021
04:34PM EDT  ANI Pharmaceuticals To Present At Cantor Virtual Global Healthcare Conference 2021 Sept. 30 At 8:00 a.m. ET   Benzinga
04:30PM EDT  ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021   Business Wire
Sep 17, 2021
07:04AM EDT  ANI Pharmaceuticals, Inc. (ANIP) announced Friday the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. It is simultaneously launched from two manufacturing sites, including the site in Baudette, Minnesota.   RTTNews
06:53AM EDT  ANI Pharmaceuticals Announces Launch Of Nebivolol Tablets, 2.5 Mg, 5 Mg, 10 Mg, And 20 Mg   RTTNews
06:51AM EDT  ANI Pharma Reports Launch Of Nebivolol Tablets   Benzinga
06:50AM EDT  ANI Pharmaceuticals Announces Launch of Nebivolol Tablets   Business Wire
Sep 9, 2021
01:15PM EDT  Looking Into ANI Pharmaceuticals's Return On Capital Employed   Benzinga
Aug 31, 2021
07:40AM EDT  ANI Pharmaceuticals, Inc. (ANIP) on Tuesday said the FDA has accepted the company's supplemental New Drug Application for Purified Cortrophin Gel for multiple indications including multiple sclerosis, rheumatoid arthritis, and nephrotic syndrome.   RTTNews
07:01AM EDT  ANI: FDA Accepts Purified Cortrophin Gel SNDA For Review For Multiple Sclerosis, Rheumatoid Arthritis,Nephrotic Syndrome   RTTNews
06:51AM EDT  ANI Pharmaceuticals Announces FDA Acceptance Of Purified Cortrophin Gel Supplemental New Drug Application For Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, And Nephrotic Syndrome   Benzinga
06:50AM EDT  ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin(r) Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome   Business Wire
Aug 6, 2021
07:53AM EDT  Recap: ANI Pharmaceuticals Q2 Earnings   Benzinga
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
07:29AM EDT  ANI Pharma Q2 GAAP Loss Per Share $1.17; Adj EPS $0.67   RTTNews
07:24AM EDT  ANI Pharmaceuticals Q2 Adj. EPS $0.67 Misses $0.68 Estimate, Sales $48.60M Beat $48.05M Estimate   Benzinga
07:24AM EDT  ANI Pharmaceuticals Reports Second Quarter 2021 Results   Business Wire
04:22AM EDT  Earnings Scheduled For August 6, 2021   Benzinga
Aug 5, 2021
11:07AM EDT  Earnings Preview: ANI Pharmaceuticals   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 22, 2021
04:30PM EDT  ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021   Business Wire
Jul 6, 2021
07:23AM EDT  ANI Pharmaceuticals, Inc. (ANIP) on Tuesday said it has re-filed its supplemental new drug application (sNDA) for Cortrophin Gel with the U.S. Food and Drug Administration   RTTNews
06:54AM EDT  ANI Pharmaceuticals Re-files SNDA For Cortrophin Gel With FDA   RTTNews
06:50AM EDT  ANI Pharmaceuticals Announces Refiling Of Cortrophin sNDA With FDA   Benzinga
Jun 15, 2021
04:05PM EDT  ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021   Business Wire
Jun 1, 2021
04:06PM EDT  ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders   Business Wire
May 27, 2021
04:30PM EDT  ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021   Business Wire
May 10, 2021
09:52AM EDT  Raymond James Maintains Outperform on ANI Pharmaceuticals, Raises Price Target to $60   Benzinga
May 7, 2021
08:03AM EDT  ANI Pharma Q1 Profit Tops Estimates   RTTNews
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
06:54AM EDT  ANI Pharmaceuticals Q1 EPS $0.01 Vs Loss $0.59 Last Year   RTTNews
06:51AM EDT  ANI Pharmaceuticals Q1 EPS $1.04 Beats $0.71 Estimate, Sales $54.50M Beat $46.80M Estimate   Benzinga
06:50AM EDT  ANI Pharmaceuticals Reports First Quarter 2021 Results   Business Wire
04:12AM EDT  Earnings Scheduled For May 7, 2021   Benzinga
May 6, 2021
10:14AM EDT  Earnings Outlook for ANI Pharmaceuticals   Benzinga
Apr 26, 2021
04:30PM EDT  ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021   Business Wire
Apr 6, 2021
07:06AM EDT  ANI Pharmaceuticals, Inc. (ANIP) announced Tuesday that it has acquired the new drug applications (NDAs) for Oxistat Lotion, Veregen Ointment, and Pandel Cream and the abbreviated new drug application (ANDA) for ApexiCon E Cream from Sandoz Inc.   RTTNews
06:57AM EDT  ANI Pharmaceuticals Acquires New Drug Applications For OXISTAT Lotion, VEREGEN Ointment And Pandel Cream And Abbreviated NDA For ApexiCon E Cream   Benzinga
06:55AM EDT  ANI Pharmaceuticals Announces Acquisition Of Sandoz Inc. NDAs   RTTNews
06:50AM EDT  ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs   Business Wire
Mar 9, 2021
09:17AM EST  The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data   Benzinga
09:15AM EST  ANI Pharmaceuticals To Acquire Novitium Pharma For $163.5M   Benzinga
09:15AM EST  ANI Pharmaceuticals Q4 Adj. EPS $0.80 Misses $0.94 Estimate, Sales $57.30M Beat $54.27M Estimate   Benzinga
06:57AM EST  ANI Pharmaceuticals Inc. (ANIP) said that it agreed to buy Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities, for $163.5 million. The deal price includes $89.5 million in cash and $74 million in equity plus two potential future cash earn-outs of up to $46.5 million.   RTTNews
06:54AM EST  ANI Pharmaceuticals Q4 GAAP Loss Per Share $0.30; Adjusted Non-GAAP EPS $0.80   RTTNews
06:50AM EST  ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth   Business Wire
06:48AM EST  ANI Pharmaceuticals To Acquire Novitium Pharma For $163.5 Mln   RTTNews
06:45AM EST  ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business   Business Wire
04:09AM EST  Earnings Scheduled For March 9, 2021   Benzinga
Mar 8, 2021
10:18AM EST  ANI Pharmaceuticals's Earnings: A Preview   Benzinga
Mar 6, 2021
10:58AM EST  The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings   Benzinga
Feb 19, 2021
04:30PM EST  ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Feb 17, 2021
06:53AM EST  ANI Pharmaceuticals Announces Addition Of Three Key Pharmaceutical Executives   RTTNews
06:50AM EST  ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth   Business Wire
Feb 16, 2021
04:30PM EST  ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021   Business Wire
Feb 1, 2021
07:04AM EST  ANI Pharmaceuticals, Inc. (ANIP) Monday announced the launch of Prazosin HCl Capsules USP, 1mg and 2mg, following the U.S. Food and Drug Administration's approval of the company's prior approval supplement application.   RTTNews
06:53AM EST  ANI Pharma Announces Launch Of Prazosin Hydrochloride Capsules   RTTNews
06:51AM EST  ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride Capsules   Benzinga
06:50AM EST  ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride ("HCl") Capsules   Business Wire
Dec 17, 2020
07:09AM EST  Specialty pharmaceutical firm ANI Pharmaceuticals, Inc. (ANIP) announced Thursday that the U.S. Food and Drug Administration (FDA) approval and the launch of Aminocaproic Acid Tablets USP, 500mg.   RTTNews
06:56AM EST  ANI Pharma Announces FDA Approval And Launch Of Aminocaproic Acid Tablets   RTTNews
06:50AM EST  ANI Pharma Reports Approval, Launch Of Aminocaproic Acid Tablets   Benzinga
06:50AM EST  ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets   Business Wire
Nov 6, 2020
02:45PM EST  Stocks Trading Near 52-Week Lows On Friday, Nov. 6, 2020: ASRT, KBLMU, PNRG, YGMZ, APRE, UHT, LAIX, CLI, CORR, ANIP, CCOI, KBLM, NYC, UTL, PEI, TIG, EYEG, PVL, ZSAN, TTNP, NBRV, SFT, WPG, IFS, COGT, LMNL, PRFX, GBT, FNHC, ASMB, EPZM, UCL   Benzinga
Nov 5, 2020
08:26AM EST  ANI Pharmaceuticals, Inc. (ANIP) released a profit for third quarter that fell from the same period last year.   RTTNews
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
06:54AM EST  ANI Pharmaceuticals Q3 Adj. EPS $0.97 Beats $0.88 Estimate, Sales $53.00M Beat $51.50M Estimate   Benzinga
06:54AM EST  ANI Pharma Q3 GAAP EPS $0.04; Adj Non-GAAP EPS $0.97   RTTNews
06:50AM EST  ANI Pharmaceuticals Reports Third Quarter 2020 Results   Business Wire
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 2, 2020
08:59AM EST  Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 29, 2020
06:50AM EDT  ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial Results   Business Wire
Sep 10, 2020
07:00PM EDT  ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Aug 6, 2020
08:13AM EDT  ANI Pharmaceuticals Suspends Previously Announced 2020 Guidance   Benzinga
08:13AM EDT  ANI Pharmaceuticals Q2 Adj. EPS $0.69 Misses $1.00 Estimate, Sales $48.47M Miss $48.93M Estimate   Benzinga
07:02AM EDT  ANI Pharmaceuticals, Inc. (ANIP) announced the appointments of Jeanne Thoma, and Antonio Pera to the company's Board of Directors. The appointments are effective immediately and increase Board to seven members.   RTTNews
06:53AM EDT  ANI Pharma Q2 GAAP Loss Per Share $1.03; Adj EPS $0.69   RTTNews
06:51AM EDT  ANI Pharmaceuticals Appoints Jeanne Thoma And Antonio "Tony" Pera To Board   RTTNews
06:50AM EDT  ANI Pharmaceuticals Reports Second Quarter 2020 Results   Business Wire
06:45AM EDT  ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio "Tony" Pera to Board of Directors   Business Wire
Aug 3, 2020
08:38AM EDT  Raymond James Maintains Outperform on ANI Pharmaceuticals, Lowers Price Target to $40   Benzinga
06:56AM EDT  ANI Pharma Names Nikhil Lalwani As President And CEO, Effective Sept 8, 2020   RTTNews
06:52AM EDT  ANI Pharmaceuticals Names Nikhil Lalwani As President And Chief Executive Officer   Benzinga
Jul 30, 2020
06:50AM EDT  ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC